Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-03 Purchase | 2023-01-04 08:30 am | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 10,000 | $0 | $0 | 15,000 (Direct) | View |
| 2021-06-18 Purchase | 2021-06-21 11:03 am | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 8,000 | $4.75 | $38,000 | 30,000 (Direct) | View |
| 2021-04-26 Purchase | 2021-04-27 4:02 pm | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 12,000 | $5 | $60,000 | 22,000 (Direct) | View |
| 2020-04-30 Purchase | 2020-05-04 2:18 pm | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 10,000 | $6 | $60,000 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-25 4:45 pm | N/A N/A | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 0 | $0 | 270,326 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-19 6:30 pm | 2025-01-01 2034-01-01 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:38 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
Ownership | 2022-12-28 8:38 pm | 2021-04-01 2031-03-30 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 0 | $0 | 17,557 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:10 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-09 Option Award | 2022-09-12 5:00 pm | N/A 2032-09-09 | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 37,600 | $0 | 37,600 (Direct) | View |
| 2021-08-19 Option Award | 2021-09-17 4:17 pm | N/A 2031-08-19 | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 38,135 | $0 | 38,135 (Direct) | View |
Ownership | 2021-03-17 8:43 pm | N/A 2031-01-22 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 0 | $0 | 10,000 (Direct) | View |
| 2020-09-09 Option Award | 2020-09-11 5:20 pm | N/A 2030-09-09 | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 14,634 | $0 | 14,634 (Direct) | View |
| 2020-02-28 Option Award(A) | 2020-05-01 5:11 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | GOLDSTEIN DOV A MD Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 7:11 pm | N/A 2030-02-28 | ADMA BIOLOGICS INC. | ADMA | GOLDSTEIN DOV A MD Director | 22,500 | $0 | 22,500 (Direct) | View |